Не сдохни! Еда в борьбе за жизнь

^{‹‹61››.} Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health Part A. 2000;59(4):229–34.

^{‹‹62››.} Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson’s disease neuropathology. Neurotoxicology. 2012; 33(5):1298–304.

^{‹‹63››.} Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology. 2005;26(4):701–19.

^{‹‹64››.} Arguin H, Sanchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010; 103(10):1433–41.

^{‹‹65››.} Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.

^{‹‹66››.} Park M, Ross GW, Petrovitch H, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047–51.

^{‹‹67››.} Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Chronic administration of 1-benzyl- 1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 1996;217(1):69–71.

^{‹‹68››.} Niwa T, Yoshizumi H, Takeda N, Tatematsu A, Matsuura S, Nagatsu T. Detection of tetrahy- droisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography- mass spectrometry. Advances in Behavioral Biology. 1990;38A:313–6.

^{‹‹69››.} Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr. 1989;493(2):347–52.

^{‹‹70››.} Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun. 1987;144(2):1084–9.

^{‹‹71››.} Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.

^{‹‹72››.} Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.

^{‹‹73››.} Kistner A, Krack P. Parkinson’s disease: no milk today? Front Neurol. 2014;5:172.

^{‹‹74››.} Chen H, Zhang SM, Hernn MA, Willett WC, Ascherio A. Diet and Parkinson’s disease: a potential role of dairy products in men. Ann Neurol. 2002;52(6):793–801.

^{‹‹75››.} Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.

^{‹‹76››.} Michaëlsson K, Wolk A, Langenskiöld S, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014;349:g6015.

^{‹‹77››.} Ridel KR, Leslie ND, Gilbert DL. An updated review of the long-term neurological effects of galactosemia. Pediatr Neurol. 2005;33(3):153–61.

^{‹‹78››.} Marder K, Gu Y, Eberly S, et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013;70(11):1382–8.

^{‹‹79››.} Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–62.

^{‹‹80››.} Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease. J Neurochem. 2002;80(1):101–10.

^{‹‹81››.} Auinger P, Kieburtz K, McDermott MP. The relationship between uric acid levels and Huntington’s disease progression. Mov Disord. 2010;25(2):224–8.

^{‹‹82››.} Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008;65(6):716–23.

^{‹‹83››.} Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson’s disease: results from a meta-analysis. Can J Neurol Sci. 2013;40(1):73–9.

^{‹‹84››.} Fang P, Li X, Luo JJ, Wang H, Yang X. A double-edged sword: uric acid and neurological disorders. Brain Disord Ther. 2013;2(2):109.

^{‹‹85››.} Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008;324(1):1–7.